Cargando…

P721: VALIDATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DEFINED BY INTERNATIONAL CONSENSUS CLASSIFICATION

Detalles Bibliográficos
Autores principales:	Hsuan Lee, Wan, Tsai, Ming-Daw, Lin, Chien-Chin, Tsai, Cheng-Hong, Tien, Feng-Ming, Lo, Min-Yen, Tseng, Mei-Hsuan, Kuo, Yuan-Yeh, Liu, Ming-Chih, Tang, Jih-Luh, -I Sun, Hsun, Chuang, Yi-Kuang, Chou, Wen-Chien, Hou, Hsin-An, Tien, Hwei-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428911/ http://dx.doi.org/10.1097/01.HS9.0000969788.43487.11

Ejemplares similares

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
por: Lee, Wan-Hsuan, et al.
Publicado: (2023)

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
por: Hou, Hsin-An, et al.
Publicado: (2018)

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
por: Lin, Ming-En, et al.
Publicado: (2018)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
por: Tsai, Xavier Cheng-Hong, et al.
Publicado: (2023)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
por: Huang, Huai-Hsuan, et al.
Publicado: (2019)

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
por: Yao, Chi-Yuan, et al.
Publicado: (2016)

A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
por: Wang, Yu-Hung, et al.
Publicado: (2021)

Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
por: Tsai, Cheng-Hong, et al.
Publicado: (2019)

Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
por: Ko, Bor-Sheng, et al.
Publicado: (2018)

ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
por: Wang, Yu-Hung, et al.
Publicado: (2020)

Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2018)

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
por: Chen, Chien-Yuan, et al.
Publicado: (2013)

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
por: Tien, Feng-Ming, et al.
Publicado: (2018)

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype
por: Chuang, Ming-Kai, et al.
Publicado: (2015)

Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
por: Wang, Yu‐Hung, et al.
Publicado: (2022)

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
por: Hou, Hsin-An, et al.
Publicado: (2016)

721 Defining Bleeding Characteristics in Frostbite Patients Managed with tPA
por: Murphy, Jenna E, et al.
Publicado: (2022)

High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia
por: Chen, Chien-Yuan, et al.
Publicado: (2015)

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
por: Tsai, Cheng-Hong, et al.
Publicado: (2017)

Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
por: Wang, Yu‐Hung, et al.
Publicado: (2021)

The Ordering of Shannon Entropies for the Multivariate Distributions and Distributions of Eigenvalues
por: Tsai, Ming-Tien, et al.
Publicado: (2019)

Insights into phenotypic differences between humans and mice with p.T721M and other C-terminal variants of the SLC26A4 gene
por: Hu, Chin-Ju, et al.
Publicado: (2021)

Clinical Efficacy and Safety of Chinese Herbal Medicine in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
por: Lu, Ping-Hsun, et al.
Publicado: (2022)

Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
por: Tien, Feng-Ming, et al.
Publicado: (2023)

Intracranial hemorrhage in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2012)

The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model
por: Hsu, Yueh-Chwen, et al.
Publicado: (2017)

721 The Rising Use of Fire as a Weapon
por: Woods, Jason, et al.
Publicado: (2023)

Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis
por: Lin, Shih-Chiang, et al.
Publicado: (2022)

Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: A multivariate meta-analysis
por: Yeh, Tzu-Lin, et al.
Publicado: (2023)

Defining medical deserts—an international consensus-building exercise
por: Brînzac, Monica G, et al.
Publicado: (2023)

PD‐L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
por: Lee, Sze‐Hwei, et al.
Publicado: (2021)

High BM plasma S100A8/A9 is associated with a perturbed microenvironmentand poor prognosis in myelodysplastic syndromes
por: Wang, Yu-Hung, et al.
Publicado: (2023)

Clinical and Prognostic Implications of Roundabout 4 (Robo4) in Adult Patients with Acute Myeloid Leukemia
por: Chen, Yin-Kai, et al.
Publicado: (2015)

Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
por: Cheng, Chieh-Lung, et al.
Publicado: (2015)

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2014)

Synthesis of composite magnetic nanoparticles Fe(3)O(4) with alendronate for osteoporosis treatment
por: Lee, Ming-Song, et al.
Publicado: (2016)

Enhanced Electrochemical Catalytic Efficiencies of Electrochemically Deposited Platinum Nanocubes as a Counter Electrode for Dye-Sensitized Solar Cells
por: Wei, Yu-Hsuan, et al.
Publicado: (2015)

Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis
por: Yu, Kuang-Hui, et al.
Publicado: (2022)

S171: HIGHER MDMX EXPRESSION WAS ASSOCIATED WITH HYPOMETHYLATING AGENT RESISTANCE AND WORSE SURVIVAL IN MYELODYSPLASTIC SYNDROME PATIENTS, INFERRING IT A POTENTIAL THERAPEUTIC TARGET
por: Wang, Yu-Hung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v28i1111kffv8cn54mpfkv9gv6